scholarly journals Gonadal Agenesis with Tetany and Severe Osteoporosis

BMJ ◽  
1956 ◽  
Vol 2 (4987) ◽  
pp. 282-283 ◽  
Author(s):  
T. J. Geffen
1998 ◽  
Vol 247 (3) ◽  
pp. 610-615 ◽  
Author(s):  
Atsuko Mizuno ◽  
Norio Amizuka ◽  
Kazuharu Irie ◽  
Akihiko Murakami ◽  
Nobuaki Fujise ◽  
...  

Author(s):  
Prema M. Naidu ◽  
Zakia Mehdi
Keyword(s):  

2010 ◽  
Vol 77 ◽  
pp. S113-S116 ◽  
Author(s):  
Ariane Leboime ◽  
Claire David ◽  
Nadia Mehsen ◽  
Julien Paccou ◽  
Cyrille B. Confavreux ◽  
...  

2016 ◽  
Vol 7 (10) ◽  
pp. 467-470
Author(s):  
Merita Emini ◽  
Nadije Morina ◽  
Idriz Gerqari ◽  
Ilir Alimehmeti

2021 ◽  
Vol 12 (3) ◽  
pp. 284-288
Author(s):  
Florina-Ligia POPA ◽  
Madalina Gabriela ILIESCU ◽  
Mihaela STANCIU ◽  
Vlad GEORGEANU

Introduction. Osteoporosis has a major influence on the quality of life because of its impact on bone strength. Osteoporosis and fractures are frequent in patients with multiple sclerosis, decreased mobility being an important risk factor in these patients. Objectives. This paper presents a case of severe osteoporosis in a patient with multiple sclerosis, to emphasize a correlation between this two pathologies. Material and Methods. We present the case of a female Caucasian patient, aged 65 years, known with progressive multiple sclerosis, on long-term use of glucocorticoids, and severe osteoporosis, who is investigated for mechanical pain and functional deficiency in the lumbar spine and the right hip, motor deficit, predominantly on right limbs and walking disorders. The patient was diagnosed with severe osteoporosis treated with raloxifene and bisphosphonates, with multiple vertebral fractures and vitamin D deficiency. During hospitalization the patient followed myorelaxant therapy and an individualized rehabilitation program. Results and discussion. During follow-up, there was a significant increase followed by a recent decrease in bone mass density in the lumbar spine and hip. The patient was recommended a loading dose of cholecalciferol for three months and initiation of teriparatide therapy after restoring 25-hydroxy vitamin D levels. Conclusion. In patients with multiple sclerosis,screening and early management of osteoporosis and osteopenia are essential. Keywords: multiple sclerosis, glucocorticoid therapy, osteoporosis,


2013 ◽  
Vol 16 (2) ◽  
pp. 32-40
Author(s):  
Zh E BELAYa ◽  
L Ya ROZhINSKAYa

This review of the literature has been dedicated to experimental and clinical studies of mechanism of action and efficacy of 1—34 amino acid fragment of parathyroid hormone — teriparatide as well as others contries experience of its prescribtion. Teriparatide is an osteoanabolic agent which stimulates bone formation by affecting bone modeling and by stimulating bone remodeling. The effects on modeling lead to increased bone formation whereas the effects on bone remodeling lead to increased bone turnover. Thus, in its mode of action teriparatide differs from all others medicines currently available to treat osteoporosis. Daily subcutaneous injections of teriparatide are proved to be effective to prevent low-traumatic vertebral and non-vertebral fractures in postmenopausal women with the history of vertebral fractures. Teriparatide is effective to treat osteoporosis in male and even more effective than alendronate to treat glucocorticoid-induced osteoporosis. Due to high cost and some restriction related to the duration of therapy (up to 18 months in Russia and 24 months in others countries) teriparatide should be recommended to treat severe osteoporosis in patients with a history >1 moderate clinical vertebral fracture or two or more vertebral fragility fractures or in case the previous treatment was not effective. Teriparatide should be prescribed after bisphosphonates or other antiosteoporotic treatment, but not in the combination with bisphosphonates. The prescribtion of bisphosphonates after teriparatide is effective to maintaine and further improve the effect. Thus, teriparatide is effective to treat severe osteoporosis and osteoporosis resistant to other therapy.


Sign in / Sign up

Export Citation Format

Share Document